NFKB1 and neoplasm: In lung adenocarcinoma (LUAD) treatment experiments, Poly I:C upregulated PD-L1 expression by activating the NF-κB signaling pathway, while simultaneously enhancing immune cell infiltration, antigen presentation, and immune activation within the tumor immune microenvironment.